WSU RESEARCHER WORKS TO ADVANCE PEPTIDE-BASED MALE CONTRACEPTIVE TOWARD HUMAN TRIALS

PULLMAN, Wash., Nov. 2 -- Washington State University issued the following news release:

The GLP-1 peptide craze that has transformed weight-loss treatment could soon expand to the bedroom and under the sheets.

Washington State University Regents Professor Jon Oatley has received a $274,849 grant from the Washington Research Foundation to help prepare Alphatide - a promising peptide-based male contraceptive he developed that works by targeting and inhibiting proteins essential for sperm development - for human clinical trials. Like GLP-1 medications, Alphatide is based on a peptide, a short chain of amino acids, but it targets an entirely different biological process.

"The World Health Organization estimates roughly 50% of pregnancies ar...